Cognitive changes during topiramate therapy.
Davanzo
P
P
Cantwell
E
E
Kleiner
J
J
Baltaxe
C
C
Najera
B
B
Crecelius
G
G
McCracken
J
J
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D003072:Cognition Disorders / Q000139:chemically induced*; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D000077236:Topiramate
D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose